<DOC>
	<DOCNO>NCT01421277</DOCNO>
	<brief_summary>This study describe reason triptan utilization pattern ( continuation discontinuation ) triptan-naïve participant assess stability treatment utilization pattern time accord standard medical guideline clinical practice standard investigate physician .</brief_summary>
	<brief_title>Study Treatment Used Migraine Headaches ( MK-0974-076 )</brief_title>
	<detailed_description>After study start , Protocol amend clarifiy first triptan prescription must receive participant within time window 3 month ( ± 2 week ) prior participant identify Investigator , could enrol study within 6 month take prescribed triptan medication first time use sample triptan would disqualify participant long sample triptan eventually prescribe .</detailed_description>
	<mesh_term>Migraine Disorders</mesh_term>
	<criteria>Inclusion criterion : At least 18 year age United States time consent Physiciandiagnosed migraine without aura At least two maximum 8 moderate severe migraine attack 30 day prior screen Initial triptan prescription 3 month ( ± 2 week ) prior identify eligible study , triptannaïve initial prescription Used triptan medication least within 6 month prior date informed consent screen Internet access able complete online survey via electronic data entry Exclusion criterion : Treated triptans prior study In active litigation compensation issue include disability dispute case Government agency Participation clinical trial within last 90 day</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2015</verification_date>
</DOC>